Xlife Sciences AG
XLS
Company Profile
Business description
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high-unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments, which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial Intelligence/Digital Medicine.
Contact
Talacker 35
Zurich8001
CHET: +41 443858460
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
20
Stocks News & Analysis
stocks
Tesla: Shares down despite record deliveries
We think the positive third-quarter numbers will be largely offset by a weak fourth quarter.
stocks
ASX listed share dominates their industry
Shares are currently fairly valued with a Wide Moat rating.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,288.10 | 53.60 | 0.58% |
CAC 40 | 8,081.54 | 24.91 | 0.31% |
DAX 40 | 24,378.80 | 43.76 | -0.18% |
Dow JONES (US) | 46,803.51 | 283.79 | 0.61% |
FTSE 100 | 9,491.25 | 63.52 | 0.67% |
HKSE | 27,140.92 | 146.20 | -0.54% |
NASDAQ | 22,785.17 | 58.88 | -0.26% |
Nikkei 225 | 45,769.50 | 832.77 | 1.85% |
NZX 50 Index | 13,514.09 | 62.33 | 0.46% |
S&P 500 | 6,720.34 | 4.99 | 0.07% |
S&P/ASX 200 | 8,987.40 | 50.80 | 0.57% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |